Dr. Fred M. Baik, MD

Dr. Baik practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Baik's NPI, 1215226568, was assigned on April 6, 2011. Dr. Baik graduated from UC San Diego School of Medicine in 2011. Dr. Baik's California license number on file is A156016.

Dr. Baik's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Baik's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Baik to 1 more hospital and 1 medical group, each named with a free account. Dr. Baik's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baik practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Baik's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Baik is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Baik's licenses on file in 3 states: California, New York and Washington.

CMS data shows 127 Medicare services from Dr. Baik across 3 procedure codes in 2024, for 113 Medicare patients. Medicare paid $9,568 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Baik in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baik's median patient age at 67, with 43% women.

In 2024, Dr. Baik wrote 15 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $88 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Baik for performance year 2024, reported as part of a group. Dr. Baik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baik as offering telehealth. CMS counts 21 procedures of melanoma (skin cancer) excision by Dr. Baik, more than 75% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Baik, published from 2007 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. Dr. Baik has published most often in Laryngoscope. Dr. Baik's most frequent co-authors are Eben L. Rosenthal, MD, Mark Lawrence Urken, MD and Kayvon Faeghi Sharif, MD.

Dmand AI links Dr. Baik to 2 clinical trials. Conditions studied include Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 11 general payments to Dr. Baik from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $409.

Dmand AI lists 1 award for Dr. Baik.

Dr. Baik graduated from UC San Diego School of Medicine in 2011. Dr. Baik is a member of NHS.

Dr. Baik is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.